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Valley Fever
and the Expanding Geographic Range of Coccidioides 
Valley fever, a fungal infection also called coccidioidomycosis, 
is a major cause of illness in the southwestern United States. 
Although most reported Valley fever cases are from Arizona 
(nearly 70%) or California (nearly 30%), some people get 
Valley fever after being exposed to the fungus Coccidioides 
in other areas. The geographic range of this fungus is likely 
larger than previously recognized; for example, it was found in 
Washington State.
From soil to lungs
People and animals can get Valley fever by breathing in the 
fungus Coccidioides from the environment. The fungus lives in 
certain areas of the western United States and parts of Mexico 
and Central and South America. Valley fever can cause flu-like 
symptoms that may last for weeks to months.
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Map of the approximate areas (“endemic areas”) where Coccidioides is 
known to live or is suspected to live in the United States and Mexico.
Common symptoms may lead to delayed diagnosis and treatment
Valley fever symptoms (fatigue, cough, fever, headache, and muscle aches or joint pain) are similar to other common illnesses, so 
diagnosis and treatment are often delayed. In a small number of people, the infection can cause chronic pneumonia, spread from 
the lungs to other parts of the body and cause meningitis (brain or spine infection), or even lead to death. 
Geographic range of Valley fever expands to 
Washington State
Scientists believed that Coccidioides only lived in the Southwestern United States and 
parts of Latin America until discovering it in south-central Washington in 2013 after 
several residents developed Valley fever without recent travel to areas where the fungus 
is known to live. Samples from one patient and soil from the suspected exposure site 
were analyzed using a laboratory technique called whole genome sequencing and were 
found to be identical, proving that the infection was acquired in Washington. 
After this discovery, many unanswered 
questions remain: How widespread is 
Coccidioides in Washington? How did it get 
there? How long has it been living there? 
Information about where a person was 
most likely infected with Valley fever, how 
strains are related, and which areas could 
pose a risk is essential for raising awareness 
about the disease among public health 
officials, healthcare providers, and the 
public. CDC is working with state and local 
public health officials and other agencies to 
better understand where the fungus lives 
so that healthcare providers and the public 
can be aware of the risk for Valley fever. 
Coccidioides lives in dry, dusty soil. It was recently 
found in south-central Washington.
Valley fever is a 
serious, costly 
illness
Nearly 75% of 
people with Valley fever 
miss work or school for 
about two weeks. 
As many as 40% 
of people who get 
Valley fever need to 
stay in the hospital.
 
The average cost of 
a hospital stay for a 
person with Valley 
fever is almost 
$50,000.
National Center for Emerging and Zoonotic Infectious Diseases
Division of Foodborne, Waterborne, and Environmental Diseases
Changes in the 
number of cases 
may be due to:
The way cases are being 
detected and reported 
Environmental factors 
such as temperature, rainfall, 
and land use 
The number of susceptible 
people exposed to Coccidioides
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Valley fever causes more severe illness in some 
groups of people
Anyone who lives in or travels to areas where Coccidioides is in the environment can get Valley fever. Valley fever can affect 
people of any age, but it’s most common in adults older than 60. Certain groups of people may be at higher risk for developing 
severe forms of the infection, including people who have weakened immune systems, pregnant women, people with diabetes, 
and people who are black or Filipino.
CDC is taking action by:
 • Supporting states to track and better understand the impact of Valley fever 
on local communities.
 • Monitoring the epidemiology of Valley fever to understand national trends 
in illnesses.
 • Developing new tools to detect Coccidioides faster and more easily in the 
environment.
 • Serving as a reference laboratory for state health departments and providing 
training in laboratory diagnosis. 
 • Increasing awareness of Valley fever among healthcare providers and the 
public to minimize delays in diagnosis and treatment.
Future directions for reducing the burden of Valley fever include:
 • Better understanding the full geographic distribution of Coccidioides to recognize which areas pose a risk.
 • More research on the prevention of Valley fever and how to reduce the severity and duration of illness. 
 • Developing better tests to diagnose Valley fever more quickly and accurately.
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